Skip to main content

Table 3 Antibiotics resistant pattern of nasal and perirectal enterococci by disc diffusion method

From: Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities

Antibiotic discs (abbreviations) Nasal isolates Perirectal isolates
  (n = 29) (n = 56)
  E. faecalis (n = 11) E. faecium (n = 18) E. faecalis (n = 29) E. faecium (n = 27)
% Resistance
Co-amoxyclav 30 μg (AMC30) 36.4 50 13.8 70.4
Ampicillin 25 μg (AMP25) 36.4 50 13.8 70.4
Cefoxitin 30 μg (FOX30) 100 100 93.1 100
Cephalexin 30 μg (CL30) 90.9 77.8 100 96.3
Cephalothin 30 μg (KF30) 81.8 66.7 75.9 96.3
Cephradine 30 μg (CE30) 81.8 94.4 100 100
Ciprofloxacin 5 μg (CIP5) 81.8 66.7 69 96.3
Erythromycin 15 μg (E15) 90.9 88.9 79.3 96.3
Gentamicin 30 μg (CN30) 72.7 83.3 79.3 92.6
Imipenem 10 μg (IPM10) 45.5 55.6 24.1 85.2
Levofloxacin 5 μg (LEV5) 45.5 50 62.1 92.6
Linezolid 30 μg (LZD30) 0 0 0 0
Methicillin 10 μg (MET10) 100 100 96.6 100
Oxacillin 1 μg (OX1) 100 100 100 100
Penicillin G 10 IU (P10) 36.4 55.6 31 85.2
Quinupristin/Dalfopristin 15 μg (QD15) 0 0 0 0
Teicoplanin 30 μg (TEC30) 18.2 5.6 10.3 11.1
Tetracycline 30 μg (TE30) 36.4 50 75.9 70.4
Vancomycin 30 μg (VA30) 18.2 5.6 10.3 11.1